AP1G1

Chr 16ADAR

adaptor related protein complex 1 subunit gamma 1

Also known as: ADTG, CLAPG1, USRISD

Adaptins are important components of clathrin-coated vesicles transporting ligand-receptor complexes from the plasma membrane or from the trans-Golgi network to lysosomes. The adaptin family of proteins is composed of four classes of molecules named alpha, beta-, beta prime- and gamma- adaptins. Adaptins, together with medium and small subunits, form a heterotetrameric complex called an adaptor, whose role is to promote the formation of clathrin-coated pits and vesicles. The protein encoded by this gene is a gamma-adaptin protein and it belongs to the adaptor complexes large subunits family. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

OMIMResearchGenerating clinical summary…
LOFmechanismAD/ARLOEUF 0.202 OMIM phenotypes
Clinical SummaryAP1G1
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder · ADStrong

Strong evidence — appropriate for clinical testing

2 total gene-disease associations curated

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
26 unique Pathogenic / Likely Pathogenic· 120 VUS of 220 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.20LOEUF
pLI 1.000
Z-score 6.05
OE 0.10 (0.050.20)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
2.98Z-score
OE missense 0.61 (0.550.67)
277 obs / 456.4 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.10 (0.050.20)
00.351.4
Missense OE?0.61 (0.550.67)
00.61.4
Synonymous OE?1.03
01.21.6
LoF obs/exp: 5 / 52.2Missense obs/exp: 277 / 456.4Syn Z: -0.30
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongAP1G1-related intellectual disability and epilepsyLOFAD
limitedAP1G1-related intellectual disabilityOTHERAR

This gene — mechanism propensity

DN
0.4289th %ile
GOF
0.4480th %ile
LOF
0.61top 25%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOF1 literature citation · 69% of P/LP variants are LoF · LOEUF 0.20

Literature Evidence

LOFThe frameshift mutations caused a loss of AP1G1 protein expression, suggesting haploinsufficiency.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 34102099

ClinVar Variant Classifications

220 submitted variants in ClinVar

Classification Summary

Pathogenic15
Likely Pathogenic11
VUS120
Likely Benign37
Benign1
Conflicting4
15
Pathogenic
11
Likely Pathogenic
120
VUS
37
Likely Benign
1
Benign
4
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
12
3
0
0
15
Likely Pathogenic
6
3
1
1
11
VUS
12
103
3
2
120
Likely Benign
0
28
4
5
37
Benign
0
0
1
0
1
Conflicting
4
Total3013798188

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

28 pathogenic / likely-pathogenic (of 44) ClinVar copy-number / structural variants overlap AP1G1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

AP1G1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →